Microbiome promotes pancreatic cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

24 citing papers in PubMed.

1. Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.Nature cancer · 2026
   Article
2. Refining antibiotic cocktail regimens for pseudo-germ-free mice and their impact on gut microbiome and pancreatic tumor proteomics.Journal of advanced research · 2026
   Article
3. Mechanistic insights into pancreatic cancer progression from circadian rhythm disruption and gut microbiota dysbiosis (Review).International journal of molecular medicine · 2026
   Review
4. Microbiota in cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
   Review
5. The Multi-dimensional Mechanisms and Transformation Prospects of the Intratumoral Microbiota-Arginine Metabolism Axis in Tumor Progression and Immune Regulation.International journal of medical sciences · 2026
   Review
6. The specific hallmarks, emerging roles, key mechanisms, and clinical applications of intra-tumoral microbiota in human cancers.Genes & diseases · 2026
   Review
7. Decoding the microbial blueprint of pancreatic cancer.Frontiers in medicine · 2026
   Review
8. Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.Cancers · 2025
   Review
9. Progress in Intestinal Homeostasis and Mechanisms of Pancreatic Cancer.Phenomics (Cham, Switzerland) · 2025
   Review
10. Microbiota in tumors: new factor influencing cancer development.Cancer gene therapy · 2024
    Review
11. Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis.Microbiology spectrum · 2024
    Article
12. Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy.International journal of molecular sciences · 2023
    Review
13. Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response.Microorganisms · 2023
    Review
14. Oral Microbiota and Tumor-A New Perspective of Tumor Pathogenesis.Microorganisms · 2022
    Review
15. Intratumor microbiome in cancer progression: current developments, challenges and future trends.Biomarker research · 2022
    Review
16. Human Gut Microbiota in Health and Selected Cancers.International journal of molecular sciences · 2021
    Review
17. Microbiota-Dependent Effects of IL-22.Cells · 2020
    Review
18. Gut Microbiota: Its Potential Roles in Pancreatic Cancer.Frontiers in cellular and infection microbiology · 2020
    Review
19. The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.PloS one · 2020
    Article
20. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.Molecular cancer · 2019
    Review

Corrections and comments

• Comment on
  The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.2018

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as